Voisin Consulting Life Sciences

#VCLS is the global reference partner to expedite access of #Healthtech products to regulated markets. #Medtech #Biotech #Innovation #Lifesciences #Fda #Ema

[Voisin Consulting Life Sciences @VCLSsocial]

[ Digital Life Sciences Blog ] Are you an innovator developing a software as a medical device? In this 2nd blog article of our digital health series, we explore regulations in the US. https://t.co/f0l3PnS4bl

[Voisin Consulting Life Sciences @VCLSsocial]

[ Case Study ] Are you developing a novel cultured meat product? Read our new case study: How to Optimize CMC for successful cultured meat product development.
��Read more: https://t.co/WGLMT3cv4o

[Voisin Consulting Life Sciences @VCLSsocial]

[ Cell & Gene Therapies ] Are you developing a novel cell & gene therapy for healthtech application? Such technologies fall under the regulatory status of Advanced Medicinal Therapy Products (ATMP).
👉Read more: https://t.co/g1PKchEeNh

#cellgenetherapy #ATMP

[Voisin Consulting Life Sciences @VCLSsocial]

[ Medical Devices ] Are you developing a medical device in Europe, and wondering about the guidelines on selecting a Notified Body? A Notified Body is the organization responsible for issuing the CE-certification on the product. https://t.co/KfutE4kZuz

[Voisin Consulting Life Sciences @VCLSsocial]

[ Digital Life Sciences ] Are you a innovator in life sciences developing a software? If so, this blog series may be of interest! Read more: https://t.co/a0UQB3wd0v

[Voisin Consulting Life Sciences @VCLSsocial]

[ Community ] Images from our tree planting initiative last weekend in Bengaluru, where we partnered with non-profit Hands On CSR to plant over 100 trees in the area to aid in #sustainability!

[Voisin Consulting Life Sciences @VCLSsocial]

[ Medical Devices ] Are you familiar with the importance of Quality Management Reviews for medical devices? In the blog below we share key considerations in properly integrating Quality Management Reviews into your product lifecycle.
Read more: https://t.co/ieyn56knSO

[Voisin Consulting Life Sciences @VCLSsocial]

[ Webinar ] TODAY is our live Q&A on the MHRA's ILAP scheme for HealthTech development, so this is your last chance to register for the event!
👉 Register here: https://t.co/QwYgvPxzSs
#webinar #event #UK #healthtech #MHRA #ILAP

[Voisin Consulting Life Sciences @VCLSsocial]

[ Conference ] Are you attending the Microbiome Movement Drug Development Europe conference Jan 31st to Feb 2nd? Our team will be there to share insights with you. To learn more on microbiome therapy development: https://t.co/U2Ll8H2IOq

[Voisin Consulting Life Sciences @VCLSsocial]

[ Medtech News ] Congratulations to @Roche on reaching this milestone with their companion diagnostics device, which detects PD-L1, a predictive biomarker for cancer treatment using immune checkpoints inhibitors. https://t.co/DVjwz3p4fg

[Voisin Consulting Life Sciences @VCLSsocial]

[ Conference ] This week our team will be attending the Genesis 2022 life sciences conference in London! If you have been looking for an opportunity to get in touch with us, Angela Bonich will be present and happy to answer your questions. https://t.co/SDK8CX14WV

[Voisin Consulting Life Sciences @VCLSsocial]

[ Case Study ] Struggling with CMC challenges related to your innovative healthcare product development? Find out how our team tackled the issues:
https://t.co/UULkAEtiO5

[Voisin Consulting Life Sciences @VCLSsocial]

[ Regulatory Strategy ] Want to ensure successful development & launch of your healthcare product?
VCLS provides a range of regulatory strategy services, to help you navigate the frameworks of different agencies, e.g. FDA and EMA.
👉 To find out more: https://t.co/dOczoicWzg

[Voisin Consulting Life Sciences @VCLSsocial]

[ Fundraising ] Congrats to our team on running the Marathon Vert this past weekend in Rennes, France!
Special congratulations for all your efforts Emmanuel PRADES, Brian M., Elodie lemarchand, and Enora Resloux.
https://t.co/GEPnyKJvUF

[Voisin Consulting Life Sciences @VCLSsocial]

Are you developing a medical therapy containing recombinant nucleic acids or engineered cells and/or tissues? To learn about ATMP material definitions and the obligatory standards...
https://t.co/LBIj9Y0mex

[Voisin Consulting Life Sciences @VCLSsocial]

The guidelines from the British Pharmaceutical Information and Pharmacovigilance Association (PIPA), for the Qualified Person for Pharmacovigilance (QPPV) and National Contact Person, have been revised and published! Get in touch for support: https://t.co/NlWC2pa1jC

[Voisin Consulting Life Sciences @VCLSsocial]

[ Webinar ] A reminder for you to not miss out on our patient engagement webinar on October 17th! This is a unique chance to discover more about how it helps product development - register now: https://t.co/n3CVHXLesf

[Voisin Consulting Life Sciences @VCLSsocial]

We're heading to #Connect in Pharma! Our CMC expert, Valerie Ardinaud and business experts @Hubertsuisse , are keen to meet healthtech developers looking for help in achieving their next regulatory milestone. https://t.co/dFveDky46y

[Voisin Consulting Life Sciences @VCLSsocial]

Attending #ESMO2022 and looking for regulatory advice to give you that competitive advantage? Our team would love to hear about your product development challenges! To find out more how we can help: https://t.co/n4j7M4sZm3

[Voisin Consulting Life Sciences @VCLSsocial]

📢Don't miss the opportunity to hear how @AvicennaAlly is working with Notified Bodies, to increase the acceptance of in silico evidence. The Policy Development Working Group Notified Bodies Task Force will be at the Poster session at #VPH2022 today.
https://t.co/dJzmr7OvxO